These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cases of Mixed Schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis. Rajeswarie RT; Mallik D; Rudrappa S; Gopal S Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199 [TBL] [Abstract][Full Text] [Related]
7. Management of multiple tumors in neurofibromatosis type 2 patients. Aboukais R; Bonne NX; Baroncini M; Zairi F; Schapira S; Vincent C; Lejeune JP Neurochirurgie; 2018 Nov; 64(5):364-369. PubMed ID: 26071178 [TBL] [Abstract][Full Text] [Related]
8. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution. Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091 [TBL] [Abstract][Full Text] [Related]
10. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population. Anand G; Vasallo G; Spanou M; Thomas S; Pike M; Kariyawasam DS; Mehta S; Parry A; Durie-Gair J; Nicholson J; Lascelles K; Everett V; Gibbon FM; Jarvis N; Elston J; Evans DG; Halliday D Arch Dis Child; 2018 May; 103(5):463-469. PubMed ID: 29535107 [TBL] [Abstract][Full Text] [Related]
13. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595 [TBL] [Abstract][Full Text] [Related]
14. Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study. Legoupil S; Bessis D; Picard F; Mallet S; Mazereeuw J; Phan A; Dupin-Deguine D; Kalamarides M; ; Chiaverini C Orphanet J Rare Dis; 2022 Jun; 17(1):242. PubMed ID: 35729665 [TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis 2 in the pediatric age group. Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853 [TBL] [Abstract][Full Text] [Related]
16. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2. Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714 [TBL] [Abstract][Full Text] [Related]
17. Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. Evans DG; Mason S; Huson SM; Ponder M; Harding AE; Strachan T J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):361-6. PubMed ID: 9120449 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis 2 in children presenting during the first decade of life. Gaudioso C; Listernick R; Fisher MJ; Campen CJ; Paz A; Gutmann DH Neurology; 2019 Sep; 93(10):e964-e967. PubMed ID: 31363058 [TBL] [Abstract][Full Text] [Related]
19. A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma. Chu YW; Cheuk DK; Chung BH; Bowers NL; Ha SY; Chiang AK; Chan GC BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406210 [TBL] [Abstract][Full Text] [Related]
20. Characterization of early onset neurofibromatosis type 2. Matsuo M; Ohno K; Ohtsuka F Brain Dev; 2014 Feb; 36(2):148-52. PubMed ID: 23414620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]